Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Inventory (2016 - 2025)

CV Sciences' Inventory history spans 13 years, with the latest figure at $4.1 million for Q3 2025.

  • For Q3 2025, Inventory changed N/A year-over-year to $4.1 million; the TTM value through Sep 2025 reached $4.1 million, changed N/A, while the annual FY2024 figure was $4.9 million, 13.4% down from the prior year.
  • Inventory for Q3 2025 was $4.1 million at CV Sciences, down from $4.2 million in the prior quarter.
  • Across five years, Inventory topped out at $9.2 million in Q2 2021 and bottomed at $4.1 million in Q3 2025.
  • The 5-year median for Inventory is $5.8 million (2023), against an average of $6.4 million.
  • The largest annual shift saw Inventory decreased 2.44% in 2021 before it dropped 23.9% in 2022.
  • A 5-year view of Inventory shows it stood at $8.6 million in 2021, then decreased by 23.9% to $6.6 million in 2022, then decreased by 13.84% to $5.7 million in 2023, then fell by 13.4% to $4.9 million in 2024, then fell by 16.68% to $4.1 million in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Inventory are $4.1 million (Q3 2025), $4.2 million (Q2 2025), and $4.9 million (Q4 2024).